160 related articles for article (PubMed ID: 23269414)
1. Serodiagnosis of human cutaneous anthrax in India using an indirect anti-lethal factor IgG enzyme-linked immunosorbent assay.
Ghosh N; Tomar I; Lukka H; Goel AK
Clin Vaccine Immunol; 2013 Feb; 20(2):282-6. PubMed ID: 23269414
[TBL] [Abstract][Full Text] [Related]
2. Anti-protective antigen IgG enzyme-linked immunosorbent assay for diagnosis of cutaneous anthrax in India.
Ghosh N; Goel AK
Clin Vaccine Immunol; 2012 Aug; 19(8):1238-42. PubMed ID: 22718130
[TBL] [Abstract][Full Text] [Related]
3. An ELISA using a recombinant chimera of protective antigen and lethal factor for serodiagnosis of cutaneous anthrax in India.
Varshney A; Puranik N; Kumar M; Pal V; Padmaja J; Goel AK
Biologicals; 2019 Jan; 57():55-60. PubMed ID: 30635155
[TBL] [Abstract][Full Text] [Related]
4. Evaluation of clinical and serological findings for diagnosis of cutaneous anthrax infection after an outbreak.
Gulseren D; Süzük-Yıldız S; Çelebi B; Kılıç S
Cutan Ocul Toxicol; 2017 Sep; 36(3):289-293. PubMed ID: 28076993
[TBL] [Abstract][Full Text] [Related]
5. A field usable qualitative anti-protective antigen enzyme-linked immunosorbent assay for serodiagnosis of human anthrax.
Ghosh N; Tomar I; Goel AK
Microbiol Immunol; 2013 Feb; 57(2):145-9. PubMed ID: 23252995
[TBL] [Abstract][Full Text] [Related]
6. Specific, sensitive, and quantitative enzyme-linked immunosorbent assay for human immunoglobulin G antibodies to anthrax toxin protective antigen.
Quinn CP; Semenova VA; Elie CM; Romero-Steiner S; Greene C; Li H; Stamey K; Steward-Clark E; Schmidt DS; Mothershed E; Pruckler J; Schwartz S; Benson RF; Helsel LO; Holder PF; Johnson SE; Kellum M; Messmer T; Thacker WL; Besser L; Plikaytis BD; Taylor TH; Freeman AE; Wallace KJ; Dull P; Sejvar J; Bruce E; Moreno R; Schuchat A; Lingappa JR; Martin SK; Walls J; Bronsdon M; Carlone GM; Bajani-Ari M; Ashford DA; Stephens DS; Perkins BA
Emerg Infect Dis; 2002 Oct; 8(10):1103-10. PubMed ID: 12396924
[TBL] [Abstract][Full Text] [Related]
7. Development & validation of a quantitative anti-protective antigen IgG enzyme linked immunosorbent assay for serodiagnosis of cutaneous anthrax.
Ghosh N; Gunti D; Lukka H; Reddy BR; Padmaja J; Goel AK
Indian J Med Res; 2015 Aug; 142(2):196-204. PubMed ID: 26354217
[TBL] [Abstract][Full Text] [Related]
8. Rapid, sensitive, and specific lateral-flow immunochromatographic device to measure anti-anthrax protective antigen immunoglobulin g in serum and whole blood.
Biagini RE; Sammons DL; Smith JP; MacKenzie BA; Striley CA; Snawder JE; Robertson SA; Quinn CP
Clin Vaccine Immunol; 2006 May; 13(5):541-6. PubMed ID: 16682473
[TBL] [Abstract][Full Text] [Related]
9. Serological studies of patients with cutaneous and oral-oropharyngeal anthrax from northern Thailand.
Sirisanthana T; Nelson KE; Ezzell JW; Abshire TG
Am J Trop Med Hyg; 1988 Dec; 39(6):575-81. PubMed ID: 3144920
[TBL] [Abstract][Full Text] [Related]
10. The early humoral immune response to Bacillus anthracis toxins in patients infected with cutaneous anthrax.
Brenneman KE; Doganay M; Akmal A; Goldman S; Galloway DR; Mateczun AJ; Cross AS; Baillie LW
FEMS Immunol Med Microbiol; 2011 Jul; 62(2):164-72. PubMed ID: 21401726
[TBL] [Abstract][Full Text] [Related]
11. Comparison of a multiplexed fluorescent covalent microsphere immunoassay and an enzyme-linked immunosorbent assay for measurement of human immunoglobulin G antibodies to anthrax toxins.
Biagini RE; Sammons DL; Smith JP; MacKenzie BA; Striley CA; Semenova V; Steward-Clark E; Stamey K; Freeman AE; Quinn CP; Snawder JE
Clin Diagn Lab Immunol; 2004 Jan; 11(1):50-5. PubMed ID: 14715544
[TBL] [Abstract][Full Text] [Related]
12. Evaluation of serologic tests for diagnosis of anthrax after an outbreak of cutaneous anthrax in Paraguay.
Harrison LH; Ezzell JW; Abshire TG; Kidd S; Kaufmann AF
J Infect Dis; 1989 Oct; 160(4):706-10. PubMed ID: 2507648
[TBL] [Abstract][Full Text] [Related]
13. Development and application of a Bacillus anthracis protective antigen domain-1 in-house ELISA for the detection of anti-protective antigen antibodies in cattle in Zambia.
Simbotwe M; Fujikura D; Ohnuma M; Omori R; Furuta Y; Muuka GM; Hang'ombe BM; Higashi H
PLoS One; 2018; 13(10):e0205986. PubMed ID: 30335853
[TBL] [Abstract][Full Text] [Related]
14. Qualification and performance characteristics of a quantitative enzyme-linked immunosorbent assay for human lgG antibodies to anthrax lethal factor antigen.
Selinsky CL; Whitlow VD; Smith LR; Kaslow DC; Horton HM
Biologicals; 2007 Apr; 35(2):123-9. PubMed ID: 17071101
[TBL] [Abstract][Full Text] [Related]
15. Development of antibodies to protective antigen and lethal factor components of anthrax toxin in humans and guinea pigs and their relevance to protective immunity.
Turnbull PC; Broster MG; Carman JA; Manchee RJ; Melling J
Infect Immun; 1986 May; 52(2):356-63. PubMed ID: 3084381
[TBL] [Abstract][Full Text] [Related]
16. Lethal factor toxemia and anti-protective antigen antibody activity in naturally acquired cutaneous anthrax.
Boyer AE; Quinn CP; Beesley CA; Gallegos-Candela M; Marston CK; Cronin LX; Lins RC; Stoddard RA; Li H; Schiffer J; Hossain MJ; Chakraborty A; Rahman M; Luby SP; Shieh WJ; Zaki S; Barr JR; Hoffmaster AR
J Infect Dis; 2011 Nov; 204(9):1321-7. PubMed ID: 21908727
[TBL] [Abstract][Full Text] [Related]
17. Monitoring of ELISA-reactive antibodies against anthrax protective antigen (PA), lethal factor (LF), and toxin-neutralising antibodies in serum of individuals vaccinated against anthrax with the PA-based UK anthrax vaccine.
Grunow R; Porsch-Ozcürümez M; Splettstoesser W; Buckendahl A; Hahn U; Beyer W; Böhm R; Huber M; vd Esche U; Bessler W; Frangoulidis D; Finke EJ
Vaccine; 2007 May; 25(18):3679-83. PubMed ID: 17287051
[TBL] [Abstract][Full Text] [Related]
18. Human monoclonal antibodies against anthrax lethal factor and protective antigen act independently to protect against Bacillus anthracis infection and enhance endogenous immunity to anthrax.
Albrecht MT; Li H; Williamson ED; LeButt CS; Flick-Smith HC; Quinn CP; Westra H; Galloway D; Mateczun A; Goldman S; Groen H; Baillie LW
Infect Immun; 2007 Nov; 75(11):5425-33. PubMed ID: 17646360
[TBL] [Abstract][Full Text] [Related]
19. Toxin-neutralizing antibodies elicited by naturally acquired cutaneous anthrax are elevated following severe disease and appear to target conformational epitopes.
Dumas EK; Demiraslan H; Ingram RJ; Sparks RM; Muns E; Zamora A; Larabee J; Garman L; Ballard JD; Boons GJ; James JA; Kayabas U; Doganay M; Farris AD
PLoS One; 2020; 15(4):e0230782. PubMed ID: 32294093
[TBL] [Abstract][Full Text] [Related]
20. Sequential B-cell epitopes of Bacillus anthracis lethal factor bind lethal toxin-neutralizing antibodies.
Nguyen ML; Crowe SR; Kurella S; Teryzan S; Cao B; Ballard JD; James JA; Farris AD
Infect Immun; 2009 Jan; 77(1):162-9. PubMed ID: 18981257
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
